New York State Common Retirement Fund
HOWL icon

New York State Common Retirement Fund’s Werewolf Therapeutics HOWL Stock Holding History

New York State Common Retirement Fund’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,100
Closed -$4.96K – 3257
2025
Q1 		$4.96K Hold
5,100
– – ﹤0.01% 3127
2024
Q4 		$7.55K Hold
5,100
– – ﹤0.01% 3124
2024
Q3 		$10.8K Sell
5,100
-34,800
-87% -$79.2K ﹤0.01% 3103
2024
Q2 		$97.4K Buy
+39,900
New +$192K ﹤0.01% 2874
2022
Q3 		– Sell
-187
Closed -$1K – 3351
2022
Q2 		$1K Sell
187
-13,866
-99% -$63.3K ﹤0.01% 3358
2022
Q1 		$62K Buy
14,053
+189
+1% +$1.32K ﹤0.01% 3128
2021
Q4 		$165K Sell
13,864
-901
-6% -$13.6K ﹤0.01% 2942
2021
Q3 		$253K Buy
14,765
+1,734
+13% +$29.6K ﹤0.01% 2817
2021
Q2 		$227K Buy
+13,031
New +$179K ﹤0.01% 2994

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

New York State Common Retirement Fund's HOWL Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Werewolf Therapeutics (HOWL) in Q2 2025, closing a stake of 5,100 shares — an estimated $4.96K sold.

New York State Common Retirement Fund first reported a position in HOWL in Q2 2021 and held it in 9 quarters. The position peaked at $253K in Q3 2021. 65 funds tracked by Wall St. Rank hold HOWL as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Werewolf Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 5,100 Werewolf Therapeutics shares in Q2 2025, an estimated $4.96K.
  • New York State Common Retirement Fund first reported a position in Werewolf Therapeutics in Q2 2021 and held it in 9 quarters.
  • New York State Common Retirement Fund's Werewolf Therapeutics position peaked at $253K in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.